Biotech / Pharma
Transcripta Bio
Biotech / Pharma
[subscription] Transcripta Bio, a biopharma company developing treatments for neurological and neuromuscular diseases, raised $24 million from investors including Mayo Clinic, Omnimed, and Jazz Venture Partners.. Transcripta Bio. Fwd: Francisco's $21B bet on slow-motion AI
Founded
Region
Investors
People